Cargando…
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
BACKGROUND: Since December, 2019, Wuhan, China, has experienced an outbreak of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Epidemiological and clinical characteristics of patients with COVID-19 have been reported but risk factors f...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270627/ https://www.ncbi.nlm.nih.gov/pubmed/32171076 http://dx.doi.org/10.1016/S0140-6736(20)30566-3 |
_version_ | 1783541936623190016 |
---|---|
author | Zhou, Fei Yu, Ting Du, Ronghui Fan, Guohui Liu, Ying Liu, Zhibo Xiang, Jie Wang, Yeming Song, Bin Gu, Xiaoying Guan, Lulu Wei, Yuan Li, Hui Wu, Xudong Xu, Jiuyang Tu, Shengjin Zhang, Yi Chen, Hua Cao, Bin |
author_facet | Zhou, Fei Yu, Ting Du, Ronghui Fan, Guohui Liu, Ying Liu, Zhibo Xiang, Jie Wang, Yeming Song, Bin Gu, Xiaoying Guan, Lulu Wei, Yuan Li, Hui Wu, Xudong Xu, Jiuyang Tu, Shengjin Zhang, Yi Chen, Hua Cao, Bin |
author_sort | Zhou, Fei |
collection | PubMed |
description | BACKGROUND: Since December, 2019, Wuhan, China, has experienced an outbreak of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Epidemiological and clinical characteristics of patients with COVID-19 have been reported but risk factors for mortality and a detailed clinical course of illness, including viral shedding, have not been well described. METHODS: In this retrospective, multicentre cohort study, we included all adult inpatients (≥18 years old) with laboratory-confirmed COVID-19 from Jinyintan Hospital and Wuhan Pulmonary Hospital (Wuhan, China) who had been discharged or had died by Jan 31, 2020. Demographic, clinical, treatment, and laboratory data, including serial samples for viral RNA detection, were extracted from electronic medical records and compared between survivors and non-survivors. We used univariable and multivariable logistic regression methods to explore the risk factors associated with in-hospital death. FINDINGS: 191 patients (135 from Jinyintan Hospital and 56 from Wuhan Pulmonary Hospital) were included in this study, of whom 137 were discharged and 54 died in hospital. 91 (48%) patients had a comorbidity, with hypertension being the most common (58 [30%] patients), followed by diabetes (36 [19%] patients) and coronary heart disease (15 [8%] patients). Multivariable regression showed increasing odds of in-hospital death associated with older age (odds ratio 1·10, 95% CI 1·03–1·17, per year increase; p=0·0043), higher Sequential Organ Failure Assessment (SOFA) score (5·65, 2·61–12·23; p<0·0001), and d-dimer greater than 1 μg/mL (18·42, 2·64–128·55; p=0·0033) on admission. Median duration of viral shedding was 20·0 days (IQR 17·0–24·0) in survivors, but SARS-CoV-2 was detectable until death in non-survivors. The longest observed duration of viral shedding in survivors was 37 days. INTERPRETATION: The potential risk factors of older age, high SOFA score, and d-dimer greater than 1 μg/mL could help clinicians to identify patients with poor prognosis at an early stage. Prolonged viral shedding provides the rationale for a strategy of isolation of infected patients and optimal antiviral interventions in the future. FUNDING: Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences; National Science Grant for Distinguished Young Scholars; National Key Research and Development Program of China; The Beijing Science and Technology Project; and Major Projects of National Science and Technology on New Drug Creation and Development. |
format | Online Article Text |
id | pubmed-7270627 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72706272020-06-05 Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Zhou, Fei Yu, Ting Du, Ronghui Fan, Guohui Liu, Ying Liu, Zhibo Xiang, Jie Wang, Yeming Song, Bin Gu, Xiaoying Guan, Lulu Wei, Yuan Li, Hui Wu, Xudong Xu, Jiuyang Tu, Shengjin Zhang, Yi Chen, Hua Cao, Bin Lancet Articles BACKGROUND: Since December, 2019, Wuhan, China, has experienced an outbreak of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Epidemiological and clinical characteristics of patients with COVID-19 have been reported but risk factors for mortality and a detailed clinical course of illness, including viral shedding, have not been well described. METHODS: In this retrospective, multicentre cohort study, we included all adult inpatients (≥18 years old) with laboratory-confirmed COVID-19 from Jinyintan Hospital and Wuhan Pulmonary Hospital (Wuhan, China) who had been discharged or had died by Jan 31, 2020. Demographic, clinical, treatment, and laboratory data, including serial samples for viral RNA detection, were extracted from electronic medical records and compared between survivors and non-survivors. We used univariable and multivariable logistic regression methods to explore the risk factors associated with in-hospital death. FINDINGS: 191 patients (135 from Jinyintan Hospital and 56 from Wuhan Pulmonary Hospital) were included in this study, of whom 137 were discharged and 54 died in hospital. 91 (48%) patients had a comorbidity, with hypertension being the most common (58 [30%] patients), followed by diabetes (36 [19%] patients) and coronary heart disease (15 [8%] patients). Multivariable regression showed increasing odds of in-hospital death associated with older age (odds ratio 1·10, 95% CI 1·03–1·17, per year increase; p=0·0043), higher Sequential Organ Failure Assessment (SOFA) score (5·65, 2·61–12·23; p<0·0001), and d-dimer greater than 1 μg/mL (18·42, 2·64–128·55; p=0·0033) on admission. Median duration of viral shedding was 20·0 days (IQR 17·0–24·0) in survivors, but SARS-CoV-2 was detectable until death in non-survivors. The longest observed duration of viral shedding in survivors was 37 days. INTERPRETATION: The potential risk factors of older age, high SOFA score, and d-dimer greater than 1 μg/mL could help clinicians to identify patients with poor prognosis at an early stage. Prolonged viral shedding provides the rationale for a strategy of isolation of infected patients and optimal antiviral interventions in the future. FUNDING: Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences; National Science Grant for Distinguished Young Scholars; National Key Research and Development Program of China; The Beijing Science and Technology Project; and Major Projects of National Science and Technology on New Drug Creation and Development. Elsevier Ltd. 2020 2020-03-11 /pmc/articles/PMC7270627/ /pubmed/32171076 http://dx.doi.org/10.1016/S0140-6736(20)30566-3 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Articles Zhou, Fei Yu, Ting Du, Ronghui Fan, Guohui Liu, Ying Liu, Zhibo Xiang, Jie Wang, Yeming Song, Bin Gu, Xiaoying Guan, Lulu Wei, Yuan Li, Hui Wu, Xudong Xu, Jiuyang Tu, Shengjin Zhang, Yi Chen, Hua Cao, Bin Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study |
title | Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study |
title_full | Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study |
title_fullStr | Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study |
title_full_unstemmed | Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study |
title_short | Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study |
title_sort | clinical course and risk factors for mortality of adult inpatients with covid-19 in wuhan, china: a retrospective cohort study |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270627/ https://www.ncbi.nlm.nih.gov/pubmed/32171076 http://dx.doi.org/10.1016/S0140-6736(20)30566-3 |
work_keys_str_mv | AT zhoufei clinicalcourseandriskfactorsformortalityofadultinpatientswithcovid19inwuhanchinaaretrospectivecohortstudy AT yuting clinicalcourseandriskfactorsformortalityofadultinpatientswithcovid19inwuhanchinaaretrospectivecohortstudy AT duronghui clinicalcourseandriskfactorsformortalityofadultinpatientswithcovid19inwuhanchinaaretrospectivecohortstudy AT fanguohui clinicalcourseandriskfactorsformortalityofadultinpatientswithcovid19inwuhanchinaaretrospectivecohortstudy AT liuying clinicalcourseandriskfactorsformortalityofadultinpatientswithcovid19inwuhanchinaaretrospectivecohortstudy AT liuzhibo clinicalcourseandriskfactorsformortalityofadultinpatientswithcovid19inwuhanchinaaretrospectivecohortstudy AT xiangjie clinicalcourseandriskfactorsformortalityofadultinpatientswithcovid19inwuhanchinaaretrospectivecohortstudy AT wangyeming clinicalcourseandriskfactorsformortalityofadultinpatientswithcovid19inwuhanchinaaretrospectivecohortstudy AT songbin clinicalcourseandriskfactorsformortalityofadultinpatientswithcovid19inwuhanchinaaretrospectivecohortstudy AT guxiaoying clinicalcourseandriskfactorsformortalityofadultinpatientswithcovid19inwuhanchinaaretrospectivecohortstudy AT guanlulu clinicalcourseandriskfactorsformortalityofadultinpatientswithcovid19inwuhanchinaaretrospectivecohortstudy AT weiyuan clinicalcourseandriskfactorsformortalityofadultinpatientswithcovid19inwuhanchinaaretrospectivecohortstudy AT lihui clinicalcourseandriskfactorsformortalityofadultinpatientswithcovid19inwuhanchinaaretrospectivecohortstudy AT wuxudong clinicalcourseandriskfactorsformortalityofadultinpatientswithcovid19inwuhanchinaaretrospectivecohortstudy AT xujiuyang clinicalcourseandriskfactorsformortalityofadultinpatientswithcovid19inwuhanchinaaretrospectivecohortstudy AT tushengjin clinicalcourseandriskfactorsformortalityofadultinpatientswithcovid19inwuhanchinaaretrospectivecohortstudy AT zhangyi clinicalcourseandriskfactorsformortalityofadultinpatientswithcovid19inwuhanchinaaretrospectivecohortstudy AT chenhua clinicalcourseandriskfactorsformortalityofadultinpatientswithcovid19inwuhanchinaaretrospectivecohortstudy AT caobin clinicalcourseandriskfactorsformortalityofadultinpatientswithcovid19inwuhanchinaaretrospectivecohortstudy |